NASDAQ:ORGO
Organogenesis Holdings Inc. Class A Stock News
$2.77
+0.0300 (+1.09%)
At Close: May 20, 2024
NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (NASDAQ: ORGO)
Here Is Why Bargain Hunters Would Love Fast-paced Mover Organogenesis (ORGO)
10:32am, Thursday, 30'th Nov 2023
Organogenesis (ORGO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks t
Organogenesis Holdings, Inc. (ORGO) Q3 2023 Earnings Call Transcript
10:16pm, Thursday, 09'th Nov 2023
Organogenesis Holdings, Inc. (NASDAQ:ORGO ) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Gary Gillheeney - President, CEO & Chair David Francisco - CFO Conference
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results
04:05pm, Thursday, 09'th Nov 2023
CANTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
07:30am, Thursday, 05'th Oct 2023
CANTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
Why Shares of Organogenesis Holdings Are Up Thursday
11:44am, Thursday, 28'th Sep 2023
Organogenesis focuses on advanced wound products. The company's second-quarter revenue and net income were down year over year.
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
04:05pm, Wednesday, 06'th Sep 2023
CANTON, Mass. , Sept. 06, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Why Shares of Organogenesis Holdings Are Dropping Thursday
11:54am, Thursday, 10'th Aug 2023
Organogenesis saw revenue and net income drop year over year. The company withdrew annual guidance.
3 Penny Stocks That Wall Street Analysts Can't Get Enough Of
03:33pm, Monday, 31'st Jul 2023
While the market offers ample opportunities for wild speculation, there's something about favored penny stocks by analysts that arouses interest. Don't get me wrong – whenever you're dealing with en
7 Cheap Penny Stocks to Buy According To Analysts, Targets Up To 1,090%
11:49am, Monday, 17'th Jul 2023
Interested in discovering the top penny stocks to invest in? You're certainly not the only one.
4 Cheap Penny Stocks to Buy According To Analysts, Targets Up To 230%
11:02am, Friday, 14'th Jul 2023
Want to know how to find the best penny stocks to buy now? Of course you do and you're not alone.
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023
07:30am, Monday, 10'th Jul 2023
CANTON, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
Why Shares of Organogenesis Climbed Wednesday
03:02pm, Wednesday, 24'th May 2023
An analyst updated Organogenesis' price target. Competitor Integra LifeSciences said Tuesday it was recalling a product.
TipRanks reveals the top 10 health care sector analysts of the past decade
08:20am, Sunday, 21'st May 2023
TipRanks' analyst ranking service ranks the top Wall Street firms of the past decade.
Why Shares of Organogenesis Holdings Jumped Thursday
02:33pm, Thursday, 11'th May 2023
Organogenesis said it expects sales to rise between 1% and 3% this year. The company said revenue rose by 10% year over year in the first quarter.
